CEFPROZIL
- Product NDC
- 68180-401
- 11-digit product format
- 681800401
- Labeler code
- 68180
- Product ID
- 68180-401_45d1a412-407b-48d4-be64-b9c7ec3c5205
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CEFPROZIL
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA065261
- Marketing category
- ANDA
- Marketing start
- 2005-12-01
- Substance
- CEFPROZIL
- Active strength
- 125 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CEFPROZIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFPROZIL | 125 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4W0459ZA4V |
| Rxcui | 309080, 309081 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-401-01 | CEFPROZIL | 50 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 50 | | 9 |
| 68180-401-02 | CEFPROZIL | 75 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 75 | | 9 |
| 68180-401-03 | CEFPROZIL | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 9 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFPROZIL | ACTIVE INGREDIENT | 4W0459ZA4V | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| CEFPROZIL | ACTIVE MOIETY | 4W0459ZA4V | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| ASPARTAME | INACTIVE INGREDIENT | Z0H242BBR1 | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| CARBOXYMETHYLCELLULOSE SODIUM | INACTIVE INGREDIENT | K679OBS311 | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | CEFPROZIL (CEFPROZIL) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-401 | CEFPROZIL POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250130_3ec55c0a-1456-412e-972f-352b3135c8f2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-401-01 | 68180040101 | 50 mL in 1 BOTTLE (68180-401-01) | 50 ml | 2005-12-01 | 0000-00-00 | No | No | Current |
| 68180-401-02 | 68180040102 | 75 mL in 1 BOTTLE (68180-401-02) | 75 ml | 2005-12-01 | 0000-00-00 | No | No | Current |
| 68180-401-03 | 68180040103 | 100 mL in 1 BOTTLE (68180-401-03) | 100 ml | 2005-12-01 | 0000-00-00 | No | No | Current |